Suppr超能文献

21-氨基类固醇U74389F对博来霉素诱导的大鼠肺纤维化的影响。

Effects of the 21-aminosteroid, U74389F, on bleomycin-induced pulmonary fibrosis in rats.

作者信息

McLaughlin G E, Frank L

机构信息

Department of Pediatrics, University of Miami School of Medicine, FL 33101.

出版信息

Crit Care Med. 1994 Feb;22(2):313-9. doi: 10.1097/00003246-199402000-00024.

Abstract

OBJECTIVE

To determine if a new class of agents, the 21-aminosteroids, which are reportedly potent inhibitors of iron-dependent lipid peroxidation, could protect rats from bleomycin-induced pulmonary fibrosis.

SUBJECTS

Fifty-five adult male Sprague-Dawley rats.

DESIGN

Prospective, randomized, blinded, controlled trial.

INTERVENTIONS

The rats were subjected to intratracheal bleomycin (or saline vehicle), and were then treated with the 21-aminosteroid, U74389F (20 mg/kg/day), or vehicle, for the next 7 days.

MEASUREMENTS AND MAIN RESULTS

At 21 days after bleomycin administration, pulmonary fibrosis was assessed histologically as percent of lung fields with evidence of fibrosis. Pulmonary fibrosis was assessed biochemically by measuring pulmonary elastin and hydroxyproline content. To determine if a protective effect of U74389F was linked to the 21-aminosteroid's ability to suppress lipid peroxidation, two products of lipid peroxidation were assayed in the lungs at 7 and 14 days after bleomycin exposure. By histologic assessment, the 21-aminosteroid-treated, bleomycin-exposed animals were found to have significantly decreased the extent of pulmonary fibrosis when compared with the bleomycin control group (mean 48.6 +/- 20.0 [SD] % [n = 9] vs. 68.4 +/- 19.6% [n = 11]; p < .05). In addition, lung elastin was decreased by approximately 75% (p < .05) and hydroxyproline was decreased by approximately 50% (NS) in the 21-aminosteroid-treated group when compared with the bleomycin control group. At 7 and 14 days after bleomycin exposure, all bleomycin-exposed animals had evidence of increased lipid peroxidation (conjugated dienes and thiobarbituric acid-reactive substances), but the 21-aminosteroid-treated, bleomycin-exposed animals had significantly decreased evidence of lipid peroxidation when compared with bleomycin controls.

CONCLUSIONS

The 21-aminosteroid can substantially protect animals from bleomycin-induced pulmonary fibrosis and may prove useful in other lung diseases where iron-dependent, free-radical reactions and/or lipid peroxidation are presumed mechanisms of toxicity.

摘要

目的

确定一类新型药物,即21 - 氨基类固醇(据报道是铁依赖性脂质过氧化的有效抑制剂)是否能保护大鼠免受博来霉素诱导的肺纤维化。

对象

55只成年雄性斯普拉格 - 道利大鼠。

设计

前瞻性、随机、盲法、对照试验。

干预措施

给大鼠气管内注入博来霉素(或生理盐水载体),然后在接下来的7天内用21 - 氨基类固醇U74389F(20毫克/千克/天)或载体进行治疗。

测量指标及主要结果

在给予博来霉素后21天,通过组织学评估肺纤维化,以有纤维化证据的肺野百分比表示。通过测量肺弹性蛋白和羟脯氨酸含量进行肺纤维化的生化评估。为了确定U74389F的保护作用是否与21 - 氨基类固醇抑制脂质过氧化的能力有关,在博来霉素暴露后7天和14天对肺中脂质过氧化的两种产物进行了检测。通过组织学评估,发现与博来霉素对照组相比,接受21 - 氨基类固醇治疗且暴露于博来霉素的动物肺纤维化程度显著降低(平均值分别为48.6±20.0[标准差]%[n = 9]和68.4±19.6%[n = 11];p < 0.05)。此外,与博来霉素对照组相比,21 - 氨基类固醇治疗组的肺弹性蛋白减少了约75%(p < 0.05),羟脯氨酸减少了约50%(无统计学意义)。在博来霉素暴露后7天和14天,所有暴露于博来霉素的动物都有脂质过氧化增加的证据(共轭二烯和硫代巴比妥酸反应性物质),但与博来霉素对照组相比,接受21 - 氨基类固醇治疗且暴露于博来霉素的动物脂质过氧化证据显著减少。

结论

21 - 氨基类固醇可显著保护动物免受博来霉素诱导的肺纤维化,在其他推测铁依赖性自由基反应和/或脂质过氧化为毒性机制的肺部疾病中可能有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验